CSL Limited
CSLLY22.1905.27% ( +1.110 )
CSL Limited (CSLLY)
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kin...
- Open
- 22.270
- High
- 22.610
- Low
- 22.130
- Prev. Close
- 21.080
- Volume
- 315.64K
- Turnover
- 7.05M
- Avg Price
- 22.326
- Bid/Ask Ratio
- --
- Amplitude
- 2.28%
- 52wk High
- 43.775
- Volume Ratio
- 0.91
- Turnover Ratio
- 0.02%
CSL Limited Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$24.108.61%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Index · Jul 25 at 05:30 PM
Weekend Wrap: Six dogs, five compounders and nine charts
- Simplywall · Jul 25 at 12:09 AM
CSL Stock And 2 Australian Dividend Shares For Reliable Income
- Simplywall · Jul 21 at 08:03 AM
Australian Mining Dividend Stocks Offering Yield With Earnings Growth
- prnewswire · Jul 13 at 06:00 AM
07:00 ETCSL Group acquiert IoTM Solutions pour renforcer son offre mondiale d'orchestration des eSIM
- MorningStar · Jul 8 at 06:46 AM
EU Seeks Views on Sanofi's Concessions to End Competition Probe — Update
- StockTitan · Jun 26 at 12:00 AM
CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union | CSLLY Stock News
